BOLA3P2

Across TCGA pan-cancer cohorts, BOLA3P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BOLA3P2’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where BOLA3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BOLA3P2 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

LUAD, BRCA, and KICH are the cancer types where BOLA3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BOLA3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	II,III,IV	+0.455	.002	6	view →
BRCA	Female	All	+0.145	.012	4	view →
KICH	All	All	−0.096	.009	2	view →
KIRC	Male	II,III,IV	+0.025	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

BOLA3P2–LUAD

Open the LUAD breakdown →